Abstract | PURPOSE OF REVIEW: RECENT FINDINGS: SUMMARY: The strong genetic association suggests a direct involvement of HLA in the pathogenesis of drug hypersensitivity when the HLA molecule presents an antigenic drug for T cell activation. The high sensitivity/specificity of some markers provides a plausible basis for developing tests to identify individuals at risk for drug hypersensitivity. Application of HLA-B*1502 genotyping as a screening tool before prescribing carbamazepine could be a valuable tool in preventing carbamazepine-induced SJS/TEN in south-east Asian countries.
|
Authors | Wen-Hung Chung, Shuen-Iu Hung, Yuan-Tsong Chen |
Journal | Current opinion in allergy and clinical immunology
(Curr Opin Allergy Clin Immunol)
Vol. 7
Issue 4
Pg. 317-23
(Aug 2007)
ISSN: 1528-4050 [Print] United States |
PMID | 17620823
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Dideoxynucleosides
- HLA Antigens
- HLA-B Antigens
- Carbamazepine
- Allopurinol
- abacavir
|
Topics |
- Allopurinol
(adverse effects)
- Carbamazepine
(adverse effects)
- Dideoxynucleosides
(adverse effects)
- Drug Eruptions
(genetics, immunology)
- Drug Hypersensitivity
(genetics, immunology)
- Genetic Predisposition to Disease
- HLA Antigens
(genetics)
- HLA-B Antigens
(genetics)
- Humans
- Pharmacogenetics
- Stevens-Johnson Syndrome
(genetics, immunology)
|